Jaundice in Polycystic Liver Disease: More Than Meets the Eye.
作者信息
Brandman Danielle
机构信息
Division of Gastroenterology Department of Medicine University of California San Francisco San Francisco CA.
出版信息
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):165-168. doi: 10.1002/cld.1001. eCollection 2021 Mar.
Abstract
摘要
相似文献
1
Jaundice in Polycystic Liver Disease: More Than Meets the Eye.
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):165-168. doi: 10.1002/cld.1001. eCollection 2021 Mar.
2
[Complicated polycystic liver disease with intracystic hemorrhage and obstructive jaundice].
Gastroenterol Clin Biol. 2001 Aug-Sep;25(8-9):818-22.
3
Jaundice associated with polycystic liver disease.
Am J Surg. 1978 Sep;136(3):383-6. doi: 10.1016/0002-9610(78)90300-8.
4
Pancreatic ductal adenocarcinoma associated with Potter type III cystic disease.
J Gastroenterol. 2001 Jun;36(6):422-8. doi: 10.1007/s005350170088.
5
Jaundice associated with polycystic liver disease. Relief by surgical decompression of the cysts.
Arch Surg. 1976 Jul;111(7):816-7. doi: 10.1001/archsurg.1976.01360250092019.
6
[Jaundice secondary to bile duct obstruction by polycystic liver disease].
Gac Med Mex. 2016 Sep-Oct;152(5):715-718.
7
Polycystic liver disease complicated by obstructive jaundice.
J Visc Surg. 2016 Apr;153(2):149-51. doi: 10.1016/j.jviscsurg.2015.11.016. Epub 2015 Dec 21.
8
A jaundiced view: more than meets the clinician's eye.
JAAPA. 2009 Oct;22(10):62. doi: 10.1097/01720610-200910000-00016.
9
Obstructive jaundice associated with polycystic liver disease.
HPB Surg. 1996;10(2):117-20. doi: 10.1155/1996/83547.
10
[2 CASES OF POLYCYSTIC CHANGES IN THE LIVER].
Vestn Khir Im I I Grek. 1964 Jan;92:85-6.
本文引用的文献
1
Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease.
Mayo Clin Proc Innov Qual Outcomes. 2019 May 27;3(2):149-159. doi: 10.1016/j.mayocpiqo.2019.03.004. eCollection 2019 Jun.
2
Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.
Gastroenterology. 2019 Aug;157(2):481-491.e7. doi: 10.1053/j.gastro.2019.04.018. Epub 2019 Apr 22.
3
Clinical management of polycystic liver disease.
J Hepatol. 2018 Apr;68(4):827-837. doi: 10.1016/j.jhep.2017.11.024. Epub 2017 Nov 24.
4
Polycystic liver disease: Hepatic venous outflow obstruction lesions of the noncystic parenchyma have major consequences.
Hepatology. 2018 Aug;68(2):652-662. doi: 10.1002/hep.29582. Epub 2018 Jul 11.
5
Efficacy and Safety of Aspiration Sclerotherapy of Simple Hepatic Cysts: A Systematic Review.
AJR Am J Roentgenol. 2017 Jan;208(1):201-207. doi: 10.2214/AJR.16.16130. Epub 2016 Nov 8.
6
Liver involvement in early autosomal-dominant polycystic kidney disease.
Clin Gastroenterol Hepatol. 2015 Jan;13(1):155-64.e6. doi: 10.1016/j.cgh.2014.07.051. Epub 2014 Aug 9.
7
Obstructive jaundice in polycystic liver disease related to coexisting cholangiocarcinoma.
Case Rep Gastroenterol. 2008 May 24;2(2):162-9. doi: 10.1159/000129600.
8
Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.
Gastroenterology. 2009 Nov;137(5):1661-8.e1-2. doi: 10.1053/j.gastro.2009.07.052. Epub 2009 Jul 29.
9
Role of primary cilia in the pathogenesis of polycystic kidney disease.
J Am Soc Nephrol. 2007 May;18(5):1381-8. doi: 10.1681/ASN.2006111215. Epub 2007 Apr 11.
10
High incidence of common bile duct dilatation in autosomal dominant polycystic kidney disease patients.
Am J Kidney Dis. 1996 Mar;27(3):321-6. doi: 10.1016/s0272-6386(96)90353-4.
Zotero 插件